JP2023540476A5 - - Google Patents
Info
- Publication number
- JP2023540476A5 JP2023540476A5 JP2023513508A JP2023513508A JP2023540476A5 JP 2023540476 A5 JP2023540476 A5 JP 2023540476A5 JP 2023513508 A JP2023513508 A JP 2023513508A JP 2023513508 A JP2023513508 A JP 2023513508A JP 2023540476 A5 JP2023540476 A5 JP 2023540476A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063070134P | 2020-08-25 | 2020-08-25 | |
| US63/070,134 | 2020-08-25 | ||
| US202063079421P | 2020-09-16 | 2020-09-16 | |
| US63/079,421 | 2020-09-16 | ||
| US202163136117P | 2021-01-11 | 2021-01-11 | |
| US63/136,117 | 2021-01-11 | ||
| PCT/US2021/047541 WO2022046898A1 (en) | 2020-08-25 | 2021-08-25 | Human cytomegalovirus vaccine |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023540476A JP2023540476A (ja) | 2023-09-25 |
| JP2023540476A5 true JP2023540476A5 (https=) | 2024-09-03 |
| JPWO2022046898A5 JPWO2022046898A5 (https=) | 2024-09-03 |
| JP7844442B2 JP7844442B2 (ja) | 2026-04-13 |
Family
ID=80353887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513508A Active JP7844442B2 (ja) | 2020-08-25 | 2021-08-25 | ヒトサイトメガロウイルスワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220401551A1 (https=) |
| EP (1) | EP4204001A4 (https=) |
| JP (1) | JP7844442B2 (https=) |
| KR (1) | KR20230057403A (https=) |
| CN (1) | CN116234570A (https=) |
| AU (1) | AU2021331064A1 (https=) |
| BR (1) | BR112023003009A2 (https=) |
| CA (1) | CA3193042A1 (https=) |
| IL (1) | IL300739A (https=) |
| MX (1) | MX2023002377A (https=) |
| TW (1) | TW202228771A (https=) |
| WO (1) | WO2022046898A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3595713A4 (en) | 2017-03-15 | 2021-01-13 | ModernaTX, Inc. | RESPIRATORY SYNCYTIAL VIRUS Vaccine |
| WO2023212696A1 (en) | 2022-04-29 | 2023-11-02 | Modernatx, Inc. | Lyophilized human cytomegalovirus vaccines |
| AU2023427858A1 (en) * | 2023-02-03 | 2025-05-15 | Vernagen, LLC | Respiratory syncytial virus mrna vaccine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130164289A1 (en) * | 2010-09-09 | 2013-06-27 | Virginia Commonwealth University | Human cytomegalovirus vaccine |
| EP3364981A4 (en) * | 2015-10-22 | 2019-08-07 | ModernaTX, Inc. | VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS |
| MA46584A (fr) | 2016-10-21 | 2019-08-28 | Modernatx Inc | Vaccin contre le cytomégalovirus humain |
| WO2018151816A1 (en) * | 2017-02-16 | 2018-08-23 | Modernatx, Inc. | High potency immunogenic compositions |
| EP3713601A4 (en) * | 2017-11-21 | 2022-03-09 | Modernatx, Inc. | VACCINES AGAINST EPSTEIN-BARR VIRUS |
| CA3154082A1 (en) * | 2019-09-11 | 2021-03-18 | Modernatx, Inc. | Human cytomegalovirus vaccine |
-
2021
- 2021-08-25 MX MX2023002377A patent/MX2023002377A/es unknown
- 2021-08-25 KR KR1020237009798A patent/KR20230057403A/ko not_active Withdrawn
- 2021-08-25 BR BR112023003009A patent/BR112023003009A2/pt not_active Application Discontinuation
- 2021-08-25 CN CN202180052553.XA patent/CN116234570A/zh active Pending
- 2021-08-25 WO PCT/US2021/047541 patent/WO2022046898A1/en not_active Ceased
- 2021-08-25 AU AU2021331064A patent/AU2021331064A1/en not_active Abandoned
- 2021-08-25 TW TW110131517A patent/TW202228771A/zh unknown
- 2021-08-25 JP JP2023513508A patent/JP7844442B2/ja active Active
- 2021-08-25 CA CA3193042A patent/CA3193042A1/en active Pending
- 2021-08-25 IL IL300739A patent/IL300739A/en unknown
- 2021-08-25 EP EP21862650.5A patent/EP4204001A4/en active Pending
-
2022
- 2022-06-14 US US17/840,478 patent/US20220401551A1/en not_active Abandoned